Oct. 12, 2020

Secret Government Experiments with Psychedelic Drugs

Secret Government Experiments with Psychedelic Drugs

Dr. Richard Miller is my special guest tonight to discuss how top researchers were carrying out experiments with psychedelic drugs under the direction of the government. Buy his book.



https://www.patreon.com/mysteriousradio
Become a 'Mysterious Radio Truther' to enjoy "Ad- Free" editions and get access to the ultimate catalog of archived podcasts, bonus editions right from your Apple Podcast App and many others! Plus get access to a ton of resources for members only in all facets of the mysterious phenomena happening in our world.


Follow us on Instagram @mysteriousradio
Follow us on Pinterest pinterest.com/mysteriousradio
Like us on Facebook Facebook.com/mysteriousradio



Embracing the revival of psychedelic research and the discovery of new therapeutic uses, clinical psychologist Dr. Richard Louis Miller discusses what is happening today in psychedelic medicine--and what will happen in the future--with top researchers and thinkers in this field, including Rick Doblin, Stanislav Grof, James Fadiman, Julie Holland, Dennis McKenna, David Nichols, Charles Grob, Phil Wolfson, Michael and Annie Mithoefer, Roland Griffiths, Katherine MacLean, and Robert Whitaker. 

Dr. Miller and his contributors cover the tumultuous history of early psychedelic research brought to a halt 50 years ago by the U.S. government as well as offering non-technical summaries of the most recent studies with MDMA, psilocybin, LSD, and ayahuasca. They explore the biochemistry of consciousness and the use of psychedelics for self-discovery and healing. They discuss the use of psilocybin for releasing fear in the terminally ill and the potential for MDMA-assisted psychotherapy in the treatment of PTSD. They examine Dr. Charles Grob’s research on the indigenous use and therapeutic properties of ayahuasca and Dr. Gabor Mate’s attempt to transport this plant medicine to a clinical setting with the help of Canada’s Department of National Health. 

Dr. Miller and his contributors explore the ongoing efforts to restore psychedelic therapies to the health field, the growing threat of overmedication by the pharmaceutical industry, and the links between psychiatric drugs and mental illness. They also discuss the newly shifting political climate and the push for new research, offering hope for an end to the War on Drugs and a potential renaissance of research into psychedelic medicines around the world.